Sarah Marie Pittman, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pittman’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A163813 · Current
Licensed to practise in California · since 2019 · expires 2027-07-31 · Memorial University of Newfoundland Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$29,851
Medicare paid this office $29,851 for 362 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 57 | $2,306 | $40 |
| Diagnostic mammography of both breasts | 55 | $2,282 | $41 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 85 | $2,139 | $25 |
| Mri scan of both breasts | 20 | $1,947 | $97 |
| Screening 3d breast mammography | 57 | $1,811 | $32 |
See all 16 services
| Screening mammography | 57 | $2,306 | $40 |
| Diagnostic mammography of both breasts | 55 | $2,282 | $41 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 85 | $2,139 | $25 |
| Mri scan of both breasts | 20 | $1,947 | $97 |
| Screening 3d breast mammography | 57 | $1,811 | $32 |
| Diagnostic mammography of 1 breast | 46 | $1,623 | $34 |
| Limited ultrasound scan of 1 breast | 53 | $1,563 | $29 |
| Mri scan of both breasts | 17 | $1,562 | $92 |
| Screening mammography | 35 | $1,412 | $40 |
| Diagnostic mammography of both breasts | 33 | $1,398 | $42 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 53 | $1,347 | $25 |
| Diagnostic mammography of 1 breast | 38 | $1,265 | $33 |
| Screening 3d breast mammography | 35 | $1,109 | $32 |
| Limited ultrasound scan of 1 breast | 34 | $1,055 | $31 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 12 | $351 | $29 |
| X-ray of surgical specimen | 15 | $205 | $13 |
Who their Medicare patients are
362 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 7% · Also on Medicaid 18% · Health risk score 1.00. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: Cancer 60% · High blood pressure 58% · Diabetes 22% · Coronary heart disease 17% · Chronic kidney disease 13% · Atrial fibrillation 12% · Depression 11% · Heart failure 9% · COPD 8% · Stroke 6%.
The office billed $373,993, Medicare allowed $36,319 and paid $29,851; for 734 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 362 | 734 | 73 | 1.00 | $373,993 | $29,851 |
| 2023 | 430 | 848 | 72 | 1.11 | $356,949 | $37,597 |
| 2022 | 530 | 1,087 | 73 | 0.98 | $372,755 | $45,484 |
| 2021 | 532 | 1,122 | 72 | 1.07 | $400,726 | $47,030 |
| 2020 | 594 | 1,307 | 72 | 0.99 | $381,883 | $52,362 |
| 2019 | 96 | 191 | 70 | 0.99 | $44,833 | $8,130 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Screening mammography | 101 | $4,255 | $42 |
| Screening 3d breast mammography | 101 | $3,382 | $33 |
| Mri scan of both breasts | 29 | $2,660 | $92 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 19 | $2,640 | $139 |
| Mri scan of both breasts | 27 | $2,487 | $92 |
| Diagnostic mammography of 1 breast | 63 | $2,252 | $35 |
| Diagnostic mammography of both breasts | 52 | $2,117 | $41 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 82 | $2,087 | $25 |
| Screening mammography | 39 | $1,651 | $42 |
| Limited ultrasound scan of 1 breast | 50 | $1,577 | $32 |
| Screening 3d breast mammography | 39 | $1,306 | $33 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 43 | $1,098 | $25 |
| Diagnostic mammography of both breasts | 28 | $1,071 | $38 |
| Diagnostic mammography of 1 breast | 28 | $993 | $35 |
| Limited ultrasound scan of 1 breast | 31 | $910 | $29 |
| Complete ultrasound scan of 1 breast | 18 | $684 | $38 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 12 | $398 | $31 |
| X-ray of surgical specimen | 13 | $183 | $14 |
2022: 18 services
| Screening mammography | 126 | $5,330 | $42 |
| Screening 3d breast mammography | 129 | $4,366 | $34 |
| Screening mammography | 75 | $3,167 | $42 |
| Mri scan of both breasts | 31 | $2,964 | $96 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 21 | $2,944 | $140 |
| Diagnostic mammography of both breasts | 69 | $2,720 | $39 |
| Screening 3d breast mammography | 74 | $2,500 | $34 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 99 | $2,449 | $24 |
| Diagnostic mammography of 1 breast | 61 | $2,131 | $34 |
| Mri scan of both breasts | 21 | $1,920 | $91 |
| Limited ultrasound scan of 1 breast | 63 | $1,693 | $27 |
| Diagnostic mammography of both breasts | 39 | $1,611 | $41 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 65 | $1,568 | $24 |
| Diagnostic mammography of 1 breast | 40 | $1,217 | $30 |
| Placement of locating device in breast using ultrasound guidance, first growth | 15 | $1,079 | $72 |
| Limited ultrasound scan of 1 breast | 33 | $968 | $29 |
| X-ray of surgical specimen | 25 | $384 | $14 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 11 | $237 | $22 |
2021: 18 services
| Screening mammography | 125 | $5,394 | $43 |
| Screening 3d breast mammography | 124 | $4,233 | $34 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 28 | $4,041 | $135 |
| Diagnostic mammography of both breasts | 91 | $3,432 | $38 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 133 | $3,116 | $23 |
| Diagnostic mammography of 1 breast | 85 | $2,733 | $31 |
| Screening mammography | 56 | $2,414 | $43 |
| Mri scan of both breasts | 20 | $1,970 | $98 |
| Screening 3d breast mammography | 56 | $1,910 | $34 |
| Limited ultrasound scan of 1 breast | 69 | $1,871 | $26 |
| Mri scan of both breasts | 21 | $1,806 | $86 |
| Diagnostic mammography of both breasts | 37 | $1,668 | $45 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 11 | $1,505 | $137 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 53 | $1,447 | $27 |
| Limited ultrasound scan of 1 breast | 33 | $1,036 | $31 |
| Diagnostic mammography of 1 breast | 27 | $887 | $33 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 26 | $557 | $20 |
| X-ray of surgical specimen | 22 | $344 | $14 |
2020: 19 services
| Screening mammography | 144 | $6,368 | $44 |
| Diagnostic mammography of both breasts | 133 | $5,323 | $40 |
| Screening 3d breast mammography | 145 | $5,034 | $35 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 188 | $4,618 | $24 |
| Limited ultrasound scan of 1 breast | 105 | $3,328 | $29 |
| Diagnostic mammography of 1 breast | 89 | $2,986 | $32 |
| Screening mammography | 60 | $2,638 | $44 |
| Mri scan of both breasts | 21 | $2,084 | $99 |
| Screening 3d breast mammography | 60 | $2,070 | $35 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 14 | $2,051 | $147 |
| Mri scan of both breasts | 20 | $1,998 | $100 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 12 | $1,854 | $154 |
| Diagnostic mammography of both breasts | 44 | $1,585 | $36 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 57 | $1,351 | $23 |
| Limited ultrasound scan of 1 breast | 37 | $1,088 | $28 |
| Diagnostic mammography of 1 breast | 21 | $763 | $35 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 20 | $454 | $23 |
| X-ray of surgical specimen | 16 | $278 | $15 |
| X-ray of surgical specimen | 14 | $233 | $15 |
2019: 7 services
| Screening mammography | 30 | $1,290 | $43 |
| Screening 3d breast mammography | 30 | $1,016 | $34 |
| Screening mammography | 14 | $600 | $43 |
| Diagnostic mammography of both breasts | 14 | $590 | $42 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 20 | $515 | $26 |
| Screening 3d breast mammography | 14 | $473 | $34 |
| Limited ultrasound scan of 1 breast | 12 | $416 | $35 |
Medicaid work
$286 in 2024
Medicaid paid $286 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 13 | $286 |
| 2024 | 13 | 1 | 13 | $286 |
| 2022 | 26 | 1 | 13 | $539 |
| 2021 | 29 | 2 | 14 | $889 |
| 2020 | 64 | 3 | 13 | $1,599 |
See the largest Medicaid services in earlier years
2022
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 26 | $539 |
2021
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 17 | $598 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 12 | $291 |
2020
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 39 | $812 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ BI | 12 | $449 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 13 | $339 |
Money from drug and device companies
$847 in 2025
A payment is not proof that care is biased.
| Merit Medical Systems | Savi Scout | $700 | 2 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $147 | 1 payment
|
See all 3 published payments
| Abbvie | Meals · 2025-12-16 | Natrelle Saline-Filled Breast Implants | $147 |
| Merit Medical Systems | Consulting · 2025-08-20 | Savi Scout | $350 |
| Merit Medical Systems | Consulting · 2025-08-04 | Savi Scout | $350 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1881240604
- Licence
- CA A163813California A163813: Current · expires 2027-07-31
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Diagnostic radiology (2085R0202X); Federal specialty code 207U00000X (207U00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2019-08-16
- NPI last updated
- 2024-04-07
- NPI record certified
- 2024-04-07
This is when the NPI record was last certified, not a medical board exam.